Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles (Q73568106)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

Thomas A Engler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kelly Furness

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Sushant Malhotra

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Concha Sanchez-Martinez

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Chuan Shih

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Walter Xie

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Guoxin Zhu

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Xun Zhou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Scott Conner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Margaret M Faul

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kevin A Sullivan

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Stanley P Kolis

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Harold B Brooks

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Bharvin Patel

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Richard M Schultz

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Tammy B DeHahn

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Kashif Kirmani

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Charles D Spencer

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Scott A Watkins

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Eileen L Considine

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Jack A Dempsey

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Catherine A Ogg

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Nancy B Stamm

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Bryan D Anderson

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Robert M Campbell

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Vasu Vasudevan

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

Michelle L Lytle

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

language of work or name

English

0 references

publication date

1 July 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

Bioorganic & Medicinal Chemistry Letters

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

2261-2267

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

Cyclins and cyclin-dependent kinases: take your partners

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Cyclin-dependent kinases: engines, clocks, and microprocessors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Cyclin-Dependent Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Cyclin-dependent kinase inhibitors for treating cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Cyclin-dependent kinases inhibitors as potential anticancer, antineurodegenerative, antiviral and antiparasitic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2)

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 2. Probing the indeno ring substituent pattern

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Quinazolines as cyclin dependent kinase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Oxindole-based inhibitors of cyclin-dependent kinase 2 (CDK2): design, synthesis, enzymatic activities, and X-ray crystallographic analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Synthesis, Structure−Activity Relationship, and Biological Studies of Indolocarbazoles as Potent Cyclin D1-CDK4 Inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

1 reference

7 January 2021

A cell cycle regulator potentially involved in genesis of many tumor types

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Overexpression of cyclin D1 and cdk4 in tumorigenesis of sporadic hepatoblastomas

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

beta-Catenin, Cyclins, and More: New Insights into the Pathogenesis, Treatment, and Prevention of Colon Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Regulation of GSK-3: a cellular multiprocessor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

APC, signal transduction and genetic instability in colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

GSK3 takes centre stage more than 20 years after its discovery

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Glycogen synthase kinase-3: properties, functions, and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Wnt signaling to beta-catenin involves two interactive components. Glycogen synthase kinase-3beta inhibition and activation of protein kinase C.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

The cyclin D1 gene is a target of the beta-catenin/LEF-1 pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Glycogen synthase kinase 3: an emerging therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

The role of beta-catenin in cell adhesion, signal transduction, and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

The oncogenic activation of beta-catenin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Structure-based generation of a new class of potent Cdk4 inhibitors: new de novo design strategy and library design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

A novel approach for the development of selective Cdk4 inhibitors: library design based on locations of Cdk4 specific amino acid residues

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Identification of selective inhibitors of cyclin dependent kinase 4

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Synthesis of quinolinyl/isoquinolinyl[a]pyrrolo [3,4-c] carbazoles as cyclin D1/CDK4 inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

A New, Efficient Method for the Synthesis of Bisindolylmaleimides

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

The reaction of vinyl grignard reagents with 2-substituted nitroarenes: A new approach to the synthesis of 7-substituted indoles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Mechanistic studies on the reaction of nitro- and nitrosoarenes with vinyl Grignard reagents

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

The Synthesis of 7-Alkoxyindoles

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Purification, characterization, and kinetic mechanism of cyclin D1. CDK4, a major target for cell cycle regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Overview of nucleic acid analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2803%2900461-X

7 January 2021

10.1016/S0960-894X(03)00461-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12824014%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference